RE-BVS – Piemonte Repository

Sfoglia per AUTORE
FINKE J
Collezione AOU Città della Salute di Torino

Items : 9

Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial. in Leukemia / Leukemia. 2022 Jul;36(7):1870-1878. doi: 10.1038/s41375-022-01582-5. Epub 2022 May 13.

2022
AOU Alessandria
AOU Città della Salute di Torino

Deckert M; Ponzoni M; Pennese E; Cabras G; Thurner L; Smith J; Rummel M; Hertenstein B; Schmoll HJ; Krause SW; Zanni M; Pisani F; Orsucci L; Tucci A; Panse J; Stilgenbauer S; Hess G; Keller U; Balzarotti M; Pukrop T; Gørløv JS; Linton KM; Johnson PW; Hemmaway C; Roth A; Krampera M; Ilariucci F; Fabbri A; Binder M; et alii...

Comparing outcomes of a second allogeneic hematopoietic cell transplant using HLA-matched unrelated versus T-cell replete haploidentical donors in relapsed acute lymphoblastic leukemia: a study of the Acute Leukemia Working Party of EBMT. in Bone marrow transplantation / Bone Marrow Transplant. 2021 Sep;56(9):2194-2202. doi: 10.1038/s41409-021-01317-7. Epub 2021 Apr 30.

2021
AOU Città della Salute di Torino

Brissot E; Ruggeri A; Sanz J; Diez-Martin JL; Blaise D; Benedetti F; Zuckerman T; Tischer J; Schmid C; Potter V; Kuball J; Caballero D; Brecht A; Angelucci E; Valerius T; Niittyvuopio R; Labussière-Wallet H; Gedde-Dahl T; Bornhäuser M; Bruno B; Finke J; Bazarbachi A; Ciceri F; Labopin M; Kharfan-Dabaja MA; Savani BN; Giebel S; Nagler A; Mohty M; et alii...

The outcome of two or more HLA loci mismatched unrelated donor hematopoietic cell transplantation for acute leukemia: an ALWP of the EBMT study. in Bone marrow transplantation / Bone Marrow Transplant. 2021 Jan;56(1):20-29. doi: 10.1038/s41409-020-0974-6. Epub 2020 Jun 19.

2021
AOU Città della Salute di Torino

Savani BN; Finke J; Franke GN; Saccardi R; Ruggeri M; Mielke S; Socié G; La Nasa G; Pioltelli P; Rambaldi A; Bruno B; Labopin M; Dholaria B; Nagler A; Ruggeri A; Mohty M;

Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMT. in British journal of haematology / Br J Haematol. 2018 Aug;182(3):418-422. doi: 10.1111/bjh.15407. Epub 2018 May 29.

2018
AOU Città della Salute di Torino

Ljungman P; Gedde-Dahl T; Cornelissen JJ; Bruno B; Beguin Y; Bay JO; Socié G; Schaap M; Itälä-Remes M; Holler E; Griskevicius L; Carlson K; Vitek A; Finke J; Van Lint MT; Blok HJP; Koster L; van Biezen A; Robin M; Szydlo R; McLornan DP; Rubio MT; Yakoub-Agha I; Klyuchnikov E; Olavarria E; Chalandon Y; Kröger N; McLornan DP; Szydlo R; et alii...

Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial. in The Lancet. Haematology / Lancet Haematol. 2017 Nov;4(11):e510-e523. doi: 10.1016/S2352-3026(17)30174-6. Epub 2017 Oct 17.

2017
AOU Città della Salute di Torino

Ferreri AJM; Cwynarski K; Pulczynski E; Fox CP; Schorb E; La Rosée P; Binder M; Fabbri A; Torri V; Minacapelli E; Falautano M; Ilariucci F; Ambrosetti A; Roth A; Hemmaway C; Johnson P; Linton KM; Pukrop T; Sønderskov Gørløv J; Balzarotti M; Hess G; Keller U; Stilgenbauer S; Panse J; Tucci A; Orsucci L; Pisani F; Levis A; Krause SW; et alii...

Long-term follow-up of a retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic transplantation from matched related donors in myelodysplastic syndromes. in Bone marrow transplantation / Bone Marrow Transplant. 2017 Aug;52(8):1107-1112. doi: 10.1038/bmt.2017.19. Epub 2017 Mar 20.

2017
AOU Città della Salute di Torino

Alvarez AF; Kalhs P; Rovira M; Leblond V; Or R; Maertens J; Volin L; Yakoub-Agha I; Bruno B; Veelken JH; Mufti GJ; Alessandrino EP; Vigouroux S; Beelen D; Finke J; Schaap N; van Lint M; Henseler A; Martino R; Vitek A; Sierra J; Wagner E; Robin M; de Witte T; Kröger N;

Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial. in The Lancet. Haematology / Lancet Haematol. 2016 May;3(5):e217-27. doi: 10.1016/S2352-3026(16)00036-3. Epub 2016 Apr 6.

2016
AOU Città della Salute di Torino

Ferreri AJ; Cwynarski K; Pulczynski E; Ponzoni M; Deckert M; Politi LS; Torri V; Fox CP; Rosée PL; Schorb E; Ambrosetti A; Roth A; Hemmaway C; Ferrari A; Linton KM; Rudà R; Binder M; Pukrop T; Balzarotti M; Fabbri A; Johnson P; Gørløv JS; Hess G; Panse J; Pisani F; Tucci A; Stilgenbauer S; Hertenstein B; Keller U; et alii...

Radioimmunotherapy in relapsed/refractory mantle cell lymphoma patients: final results of a European MCL Network Phase II Trial. in Leukemia / Leukemia. 2016 Apr;30(4):984-7. doi: 10.1038/leu.2015.215. Epub 2015 Aug 5.

2016
AOU Città della Salute di Torino

Weigert O; Hiddemann W; Passera R; Ghione P; Keller U; Finke J; Trümper L; Bergmann L; Pezzutto A; Forstpointner R; Scholz CW; Pastore A; Ferrero S; Unterhalt M; Dreyling M;

Achievement of complete remission predicts outcome of allogeneic haematopoietic stem cell transplantation in patients with chronic myelomonocytic leukaemia. A study of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation. in British journal of haematology / Br J Haematol. 2015 Oct;171(2):239-246. doi: 10.1111/bjh.13576. Epub 2015 Jul 26.

2015
AOU Città della Salute di Torino

Symeonidis A; van Biezen A; de Wreede L; Piciocchi A; Finke J; Beelen D; Bornhäuser M; Cornelissen J; Volin L; Mufti G; Chalandon Y; Ganser A; Bruno B; Niederwieser D; Kobbe G; Schwerdtfeger R; de Witte T; Robin M; Kröger N;